BTA
Click for more information
0.00% 57.0¢ biota holdings limited

article on relenza v tamiflu study

  1. peza
    56 Posts.
    clock Created with Sketch.
    05/07/08
    22:34
    Post #: 3954256

    http://today.reuters.com/misc/PrinterFriendlyPopup.aspx?type=companyNews&storyID=202001+03-Jul-2008+RTRS

    Extract:
    Doctors can feel free to choose either drug in treating children and may prefer Relenza, made by GlaxoSmithKline and known generically as zanamivir, for youths aged 10 to 19, they said.
    .....
    But because of reports of psychiatric reactions, the Health, Labor, and Welfare Ministry of Japan suspended use of Tamiflu for patients aged 10 to 19
    BTA Price at posting: 0.0¢ Sentiment: LT Buy Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply
 

Featured News

NEWS 'Future in Aussie' Budget boost could turn IGO into a Cinderella stock
right-arrow Created with Sketch.
SBW The home PC changed retail stores forever. Shekel Brainweigh can do it again
right-arrow Created with Sketch.
TLG Talga ups graphite exploration target as crit minerals stay in focus
right-arrow Created with Sketch.
BRX Sampling in Argentina points the way to a base metals porphyry for Belararox
right-arrow Created with Sketch.
AGE Alligator Energy notches up on uranium drilling start, but still early days
right-arrow Created with Sketch.
M2R Miramar upgrades target within WA's Gidji, suggests extension to Northern Star's 8 Mile Dam
right-arrow Created with Sketch.

Top Stories

watchlist Created with Sketch. Add BTA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.